Screener
Taysha Gene Therapies, Inc. TSHA Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Taysha Gene Therapies, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344610
| Line item | For the three months ended June 30, 2026 | For the three months ended June 30, 2025 | For the six months ended June 30, 2026 | For the six months ended June 30, 2025 |
|---|---|---|---|---|
| Research and development | 38,636 | 20,141 | 72,445 | 35,706 |
| General and administrative | 12,146 | 8,598 | 21,823 | 16,756 |
| Net gain on lease termination | (3,433) | — | (3,433) | — |
| Total operating expenses | 47,349 | 28,739 | 90,835 | 52,462 |
| Loss from operations | (47,349) | (26,753) | (90,835) | (48,174) |
| Other income (expense): | ||||
| Change in fair value of warrant liability | — | (273) | — | (171) |
| Change in fair value of term loan | (1,521) | (1,461) | (2,991) | (2,991) |
Item 1. Financial Statements.
FAQ
- What is Taysha Gene Therapies, Inc.'s other operating expenses?
- Taysha Gene Therapies, Inc. (TSHA) reported other operating expenses of $47.35M in Q2 2026.
- How has Taysha Gene Therapies, Inc.'s other operating expenses changed year-over-year?
- Taysha Gene Therapies, Inc.'s other operating expenses increased by 64.8% year-over-year, from $28.74M to $47.35M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s other operating expenses has grown at a -8.7% compound annual growth rate (CAGR), from $173.27M to $120.27M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Taysha Gene Therapies, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude